Texas Pandemic Influenza Regional Conference Novel H1N1 Vaccine Implementation

1
Texas Pandemic Influenza Regional
ConferenceNovel H1N1 Vaccine Implementation
Texas Department of State Health Services
(DSHS) and Texas Division of Emergency Management
(DEM)August and September, 2009
2
Presentation Outline

• Overview
• Vaccine Availability and Timing
• Who Will be Targeted for Vaccination
• Where Those Targeted for Vaccination will get
  their Vaccine
• Reporting Vaccine Usage
• Key Points

3
Vaccine ImplementationOverview

• Definition of Vaccine A vaccine is a biological
  preparation that triggers an individuals immune
  system to create antibodies that protect against
  a disease
• Texas potentially will receive a large amount of
  novel H1N1 vaccine
• DSHS will coordinate the ordering and
  distribution of the novel H1N1 vaccine in Texas
• The novel H1N1 vaccine is a separate vaccine from
  the seasonal influenza vaccine
• Both seasonal and novel H1N1 vaccines are
  necessary to prevent illness from the viruses
• Get pneumococcal (pneumonia) vaccine as
  recommended

4
Seasonal Flu Vaccine Vaccine Availability and
Timing

• Expected Date the Seasonal Vaccine will be
  Available

September
2009
5
Novel H1N1 Vaccine Vaccine Availability and Timing
Expected Date the Novel H1N1 Vaccine will be
Available
Mid-October
2009

• Novel H1N1 Vaccine will be managed by DSHS
• Novel H1N1 Vaccine ordering and distribution will
  be coordinated by DSHS and not through the
  regular distribution methods providers are
  accustomed to using

6
Vaccinations Seasonal vs. Novel H1N1
Seasonal
H1N1

• ACIP recommendations for those most at risk
  differ from seasonal flu
• Procurement by federal government
• State managed distribution to providers
• Vaccine may not be available before novel H1N1
  disease increases
• All vaccine recipients will likely need 2 doses

• Most vaccine is used in elderly and high risk
  adults
• Most vaccine procured via private health system
• Mostly private sector delivery in various
  settings
• Majority of vaccine given before flu season
  begins
• Adults and adolescents need only 1 dose

Likely confluence of seasonal and pandemic
vaccination in Fall 2009
7
Novel H1N1 Vaccine Population Priorities

• Initial groups targeted for vaccination (not in
  priority order)
• Pregnant Women
• Household contacts and caregivers for children
  younger than six months of age
• Healthcare and emergency medical services
  personnel
• All people six months through 24 years of age
• Persons 25 years through 64 years of age who have
  health conditions associated with higher risk of
  medical complications from influenza
• Once the groups above have had the opportunity to
  receive vaccine, healthy individuals 25 years of
  age and older (including senior citizens) will be
  offered vaccine
• Individuals receiving the vaccine are expected to
  need two doses

8
Novel H1N1 Vaccine Where Those Targeted for
Vaccination Will Get Their Vaccine

• Healthcare workers who offer the novel H1N1
  vaccine to those targeted for vaccination
  including doctors offices, clinics, pharmacies,
  workplaces, and hospitals, etc.
• Individuals in target groups should talk with
  their doctor or the clinic where they usually
  receive the seasonal influenza vaccine
• DSHS Regional and local health departments will
  serve as the safety-net for anyone who is not
  able to obtain the vaccine in other healthcare
  settings, particularly for the uninsured and
  underinsured
• Other resources will be available to help people
  find vaccination locations such as 2-1-1 and the
  DSHS Immunization website at www.ImmunizeTexas.com

9
Novel H1N1 Vaccine Reporting Vaccine Usage

• DSHS will be required to report vaccine usage by
  age group and by first or second dose on a weekly
  basis to the CDC.
• Providers administering the vaccine will also
  need to report vaccine usage to DSHS on a weekly
  basis through ImmTrac or systems that interface
  with it
• The National Vaccine Adverse Event Reporting
  System routinely collects information regarding
  reactions to vaccines in order to identify any
  potential safety issues with any vaccine and
  healthcare providers will need to submit these
  reports to DSHS

10
Novel H1N1 Vaccine Key Points

• Seek seasonal influenza vaccine as soon as that
  vaccine is available
• Anyone in a group targeted for novel H1N1 virus
  vaccination should be vaccinated as soon as the
  vaccine becomes available
• As guidance is available, DSHS will post
  information on www.texasflu.org

11
Novel H1N1 Vaccine Considerations
Department of State Health Services
Local Communities

• Manage vaccine distribution (allocate, process
  orders, and ship)
• Coordinate with stakeholders (healthcare
  providers, general public, etc.) regarding
  vaccine implementation
• Track and report vaccine usage
• Assist CDC with monitoring vaccine safety

• Verify population information from DSHS for
  allocation and quantity purposes
• Healthcare providers will need to register with
  DSHS to declare their vaccine needs (information
  forthcoming)
• Once vaccine has arrived, begin vaccination
  campaign
• Report vaccine usage and safety issues with
  vaccine